Skip to main content

Table 4 Study outcome definitions

From: Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Outcome domain

Specific measurement

Metric and method of aggregation

Time point of interest

Health-related quality of life

The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym) [28]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Patient experience of care

Patient Assessment of Care for Chronic Conditions (PACIC)

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Symptom distress

Memorial Symptom Assessment Scale (MSAS) [31]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Comorbidity burden

The Charleston Comorbidity Index (CCI) supplemented with items from Self-Administered Comorbidity Questionnaire (SCQ) [32]

Difference between mean change scores from baseline

12 months

Total leisure-time physical activity

Active Australia Survey [33]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Usual vegetable intake and usual fruit intake

Two short dietary questions from the National Nutrition Survey [34]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Financial distress

0–10 numerical analogue scale (where 10 is “a great deal” and 0 is “none”) [35]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Employment interference

0–10 numerical analogue scale (where 10 is “a great deal” and 0 is “none”) [36]

Effect of time on mean change score between groups

Baseline, 6 months, 12 months

Satisfaction of care

0–10 numerical analogue scale (where 10 is “most satisfied” and 0 is “least satisfied”)

Difference in mean score between groups

12 months